EMBC
Embecta Corp
NASDAQ: EMBC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$6.19
-0.96% today
Updated 2026-11-02
Market cap
$363.75M
P/E ratio
4.37
P/S ratio
0.36x
EPS (TTM)
$1.47
Dividend yield
7.41%
52W range
$3 – $14
Volume
1.1M
Embecta Corp (EMBC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$6.19
12-Month target
$11.09
2030 Target
$8.81
Intrinsic (DCF)
$9.68
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -0.09% (capped 20%) · P/E: 4.37x (capped 25x) · Margin: 8.59%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.